Creo Medical Group (CREO)

Sector:

Health Care

Index:

FTSE AIM All-Share

14.50p
   
  • Change Today:
      3.13p
  • 52 Week High: 17.75
  • 52 Week Low: 9.90
  • Currency: UK Pounds
  • Shares Issued: 412.47m
  • Volume: 5,239,705
  • Market Cap: £59.81m

Latest Deals

Traded Action Notifier PriceAmountValue
13-Jan-26 Transfer From Richard John Rees 0.000p 16,072 £0.00
13-Jan-26 Buy Richard John Rees 11.20p 8,036 £900.03
13-Jan-26 Transfer From Craig Jonathan Gulliford 0.000p 16,072 £0.00
13-Jan-26 Buy Craig Jonathan Gulliford 11.20p 8,036 £900.03
08-Aug-25 Transfer To Richard John Rees 0.000p 362,408 £0.00

Largest Deals (365 days)

Traded Action Notifier PriceAmountValue
30-May-25 Buy Kevin Crofton 15.75p 701,750 £110,525.62
22-Jul-25 Sell Craig Jonathan Gulliford 14.00p 6,429 £900.06
22-Jul-25 Sell Richard John Rees 14.00p 6,429 £900.06
13-Jan-26 Buy Craig Jonathan Gulliford 11.20p 8,036 £900.03
13-Jan-26 Buy Richard John Rees 11.20p 8,036 £900.03

Director Shareholdings

Notifier Holding Value*
Kevin Crofton 5,447,416 £789,875
Richard John Rees 2,723,627 £394,926
Craig Jonathan Gulliford 1,703,873 £247,062
Ivonne Cantu 125,000 £18,125

Major Shareholders

Notifier** Holding Value*
M&G Investments 49,583,836 £7,189,656
Canaccord Genuity Group Inc 36,167,753 £5,244,324
Baillie Gifford & Co 27,795,238 £4,030,310
Hargreave Hale Limited 22,846,245 £3,312,706
River Global Investors LLP 20,827,081 £3,019,927
AXA Framlington Investment Managers 17,066,645 £2,474,664
Amati Global Investors 15,959,536 £2,314,133
Development Bank of Wales plc 14,376,727 £2,084,625
Finance Wales 14,376,727 £2,084,625
Creo Medical Group EBT 10,000,000 £1,450,000
The Capital Group Companies, Inc. 8,816,807 £1,278,437
Tellworth Investments 5,772,778 £837,053
Hoya Corporation 4,799,880 £695,983
Jonathan Craton 3,400,294 £493,043
Cotterford Co Limited 3,335,398 £483,633
Mark Farmer 3,121,607 £452,633
RBC Trustees (CI) Ltd 2,974,727 £431,335
Angel Co Fund 2,967,120 £430,232

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

CREO Market Data

Currency UK Pounds
Share Price 14.50p
Change Today 3.13p
% Change 27.47 %
52 Week High 17.75
52 Week Low 9.90
Volume 5,239,705
Shares Issued 412.47m
Market Cap £59.81m

CREO Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
5.70% above the market average5.70% above the market average5.70% above the market average5.70% above the market average5.70% above the market average
9.09% below the sector average9.09% below the sector average9.09% below the sector average9.09% below the sector average9.09% below the sector average
Price Trend
76.94% below the market average76.94% below the market average76.94% below the market average76.94% below the market average76.94% below the market average
31.43% below the sector average31.43% below the sector average31.43% below the sector average31.43% below the sector average31.43% below the sector average
Income Not Available
Growth
46.91% below the market average46.91% below the market average46.91% below the market average46.91% below the market average46.91% below the market average
65.71% below the sector average65.71% below the sector average65.71% below the sector average65.71% below the sector average65.71% below the sector average

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 1
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

CREO Dividends

No dividends found

Trades for 22-May-2026

Time Volume / Share Price
17:05 90,000 @ 14.50p
14:47 567,266 @ 14.25p
16:05 6,849 @ 14.60p
16:04 13,698 @ 14.60p
16:04 25,000 @ 14.27p

CREO Key Personnel

CEO Craig Jonathan Gulliford
CFO Richard John Rees
Chair Kevin Crofton

Top of Page